E. Frausing Hansen (Hvidovre, Denmark), E. Omenaas (Bergen, Norway)
The costs of exacerbations in COPD
F. Andersson, S. Borg, S. A. Jansson, A. C. Jonsson, A. Lindberg, C. Prütz, E. Rönmark, B. Lundbäck (Lund, Luleå, Sweden)
|  |
Mortality risks related to smoking and low FEV1 differ in subgroups according to age and gender in a long-term follow-up - the Malmö prevention project
M. Ekberg Aronsson, P. Nilsson, J. A. Nilsson, K. Pehrsson, G. Berglund, C. G. Löfdahl (Malmö and Lund, Sweden)
| |
10 year evolution of dyspnea in an elderly cohort
C. Nejjari, J. F. Tessier, M. L. Marty, I. Baldi, L. Filleul, P. Barberger-Gateau, J. F. Dartigues (Fes, Morocco; Bordeaux, France)
| |
Oxidative stress and products of nitric oxide metabolism in COPD and in smokers
M. Calikoglu, L. Tamer, I. Calikoglu, S. Atis, B. Ulubas (Mersin, Turkey)
| |
Alcohol consumption and hospitalisations due to COPD
U. Nihlén, C. Wells, B. Lindgren, C. G. Löfdahl (Lund, Sweden)
| |
Respiratory symptoms/diseases are related to environmental tobacco smoke (ETS) in an epidemiological study on environment and health in women from four Italian areas (SEASD)
S. Baldacci, F. Pistelli, F. Di Pede, M. Simoni, E. Lo Presti, S. Farchi, R. Pistelli, G. Corbo, F. Forastiere, G. Viegi, SEASD Group (Pisa, Rome, Italy)
| |
Prevalence of chronic obstructive bronchitis (COB) among French adults
G. J. Huchon, A. Vergnenègre, F. Neukirch, T. Lebrun, C. Kuntz, J. P. Giordannella (Paris, France)
| |
Does long-term oxygen therapy reduce hospitalisation in hypoxaemic COPD?
T. J. Ringbaek, K. Viskum, P. Lange (Copenhagen, Denmark)
| |
Mortality and progression of chronic bronchitis in Germany
J. Lorenz, R. Rychlik, T. Pfeil, O. Mast, I. M. Thate-Waschke (Lüdenscheid, Burscheid, Leverkusen, Germany)
| |
The rate of hospital admissions for chronic obstructive pulmonary disease
V. Petrovic, M. Vukcevic, B. Milenkovic, L. Nagorni-Obradovic, A. Ilic (Belgrade, Yugoslavia)
| |
The predictive value of FEV1 for COPD death in construction workers
U. Hedlund, B. Järvholm (Malmberget, Umeå, Sweden)
| |
Relative survival of patients with COPD on long-term oxygen therapy
A. J. Crockett, J. M. Cranston, D. Roder, A. Nguyen (Bedford Park, Adelaide, Australia)
| |
Prevalence of chronic obstructive pulmonary disease in Japan: results from the Nippon COPD epidemiology (NICE) study
Y. Fukuchi, M. Nishimura, M. Ichinose, M. Adachi, A. Nagai, T. Kuriyama, K. Takahashi, K. Nishimura, S. Ishioka, H. Aizawa, A. Iqbal (Tokyo, Hokkaido, Miyagi, Chiba, Ishikawa, Hiroshima, Fukuoka, Japan; Santa Monica, United States Of America)
| |
Prevalence and predictors of chronic mucus hypersecretion in young Danish adults
C. S. Ulrik, M. L. V. Linstow, S. Nepper-Christensen, C. Porsbjerg, V. Backer (Copenhagen, Denmark)
| |
Respiratory symptoms assessed by postal questionnaire among elderly people in Northern Ireland
M. Magorrian, E. Murtagh, L. G. Heaney, J. Gingles, F. Kee, D. R. T. Shepherd, J. MacMahon (Belfast, United Kingdom)
| |
Dyspnea and disability level in elderly subjects from the French Quid R study
M. L. Marty, J. F. Tessier, C. Nejjari, I. Baldi, F. Neukirch, H. Guenard, C. Helmer, J. F. Dartigues, P. Barberger-Gateau (Bordeaux, Paris, France; Fes, Morocco)
| |
Elderly persons with obstructive pulmonary disease more often have other comorbidities and walking disability
J. A. Hardie, W. M. Vollmer, A. S. Buist, P. S. Bakke, O. Mørkve (Bergen, Norway; Portland, United States Of America)
| |